Racial disparities in Black men with prostate cancer: A literature review.

"CONFLICTS OF INTEREST Kelvin A. Moses reports personal fees from Myovant and Astellas/Pfizer and participation in speakers' bureaus for Astellas/Pfizer and Dendreon outside the submitted work. Brandon A. Mahal reports funding from Prostate Cancer Foundation, the American Society for Radiation Oncology, the US Department of Defense, and the National Institutes of Health; and personal fees from Myovant and the Cancer Study Group outside the submitted work. Daniel J. George reports grants from Calithera, Capio Biosciences, and EMD Serono; grants and personal fees from Astellas, Bristol‐Myers Squibb, Janssen Pharmaceuticals, Novartis, and Pfizer; personal fees from AstraZeneca, Axess Oncology, Flatiron, Ipsen, Merck Sharp & Dohme, Michael J. Hennessey Associates, Millennium Medical Publishing, Modra Pharmaceutical B.V., Myovant Sciences Inc., NCI Genitourinary, Nektar Therapeutics, Physician Education Resource, UroGPO, Vizuri Health Sciences, Platform Q, Propella Therapeutics, RevHealth, Seattle Genetics, WebMD, and Xcures; grants, personal fees, and nonfinancial support from Bayer HealthCare Pharmaceuticals, Exelixis, Inc., and Sanofi; grants from Acerta Pharmaceuticals; personal fees and nonfinancial support from UroToday and other support from the American Association for Cancer Research, all outside the submitted work. James W. Lillard made no disclosures."

"FUNDING INFORMATION Editorial support was provided by Lauren Rainer, BSc; Laura Geuss, PhD; and Julie B. Stimmel, PhD, at Onyx (a Prime Global agency) and was funded by Pfizer."